u/elin_lundgren

Tried to build a mental model from mechanism alone and produced a confident prediction that the trial data flatly contradicted.

the peripheral and central stories are not in competition

Careful — that is a dosing intuition carried over from another board and there is no basis for it here.

Glucose-dependent insulin secretion is why hypoglycaemia risk is low as monotherapy: the effect scales with glycaemia rather than acting unconditionally.

Mine settled at week 56 and has not come back since, across two more steps.

Right, and the hair thing is worth repeating: it tracks the rate of loss rather than the compound, and it stops.

GIP receptor biology is genuinely unsettled — there is a live argument about agonism versus antagonism at the receptor — and the clinical results are robust regardless, which is an uncomfortable and interesting position.

Disagree. That is a preclinical finding in a rodent model and you are stating it as human pharmacology.

Nothing containing this compound is approved as a standalone product, and research-use-only material is not approved for human use.

fibre and water before you buy anything to fix it

Correction: that is the combination programme, not the monotherapy readout. Different arms, different numbers.

What was the exposure in that experiment relative to therapeutic?

dose response is not linear and nobody should assume it is

Hair shedding after significant weight loss is a telogen effect that follows the rate of loss. It is not specific to these compounds and it resolves.

Glucose-dependent insulin secretion is why hypoglycaemia risk is low as monotherapy: the effect scales with glycaemia rather than acting unconditionally.

Constipation is mostly reduced intake plus reduced fluid, not a direct effect. That is why the boring fibre and water answer keeps working.